SCHEMBL29328550

SCHEMBL29328550

COC(=O)c1ccc(C(=O)Cn2nccc2C(=O)OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.48
▸ PLAU P00749 1/20 0.48
▸ KLKB1 P03952 1/20 0.48
▸ ELANE P08246 1/20 0.48
▸ RAB9A P51151 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 4/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20660787 0.81 F2 (0.46) F2PLAUKLKB1ELANERAB9A
SCHEMBL7056151 0.78 F2 (0.48) F2PLAUKLKB1ELANERAB9A
SCHEMBL7056155 0.78 F2 (0.48) F2PLAUKLKB1ELANERAB9A
SCHEMBL24937400 0.78 L3MBTL1 (0.56) F2PLAUKLKB1ELANERAB9A
SCHEMBL31460083 0.76 F2 (0.47) F2PLAUKLKB1ELANERAB9A
SCHEMBL30829495 0.75 F2 (0.46) F2PLAUKLKB1ELANERAB9A
SCHEMBL24875516 0.74 F2 (0.44) F2PLAUKLKB1ELANERAB9A
SCHEMBL25653535 0.73 ALDH1A1 (0.73) RAB9ANPC1LMNAMAPTCA1
SCHEMBL16427745 0.73 PDE4B (0.50) LMNAMAPTHTTALDH1A1HPGD
SCHEMBL17221597 0.73 MAPT (0.47) F2PLAUKLKB1ELANERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 — — WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 — — WO disclosed
Send feedback